Clinical Trials at UCLA
Three clinical trials are in the works to test the safety and efficacy of UCLA-developed spinal cord stimulation on people with spinal cord injuries. One, using epidural stimulation, is currently enrolling; the second and third, not yet recruiting patients, will explore arm and hand recovery, and bladder function. The latter two will utilize a cutting-edge transcutaneous stimulator—no surgery required—developed by NeuroRecovery Technologies (NRT), a company co-founded by UCLA professor Reggie Edgerton. NRT is awaiting final regulatory approvals but hopes to enroll patients soon. For information on the trials, contact Dr. Daniel Lu at the UCLA Spine Center, email@example.com
Article by The Hub SoCal © The Hub SoCal Magazine published by Style Media Group.
Article appears in the Premiere 2015 Issue of The Hub So Cal Magazine.